Found: 8
Select item for more details and to access through your institution.
Structural and immunological differences in Plasmodium falciparum sexual stage transmission-blocking vaccines comprised of Pfs25-EPA nanoparticles.
- Published in:
- NPJ Vaccines, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41541-023-00655-5
- By:
- Publication type:
- Article
Malaria transmission-blocking conjugate vaccine in ALFQ adjuvant induces durable functional immune responses in rhesus macaques.
- Published in:
- NPJ Vaccines, 2021, v. 6, n. 1, p. 1, doi. 10.1038/s41541-021-00407-3
- By:
- Publication type:
- Article
Protein-protein conjugate nanoparticles for malaria antigen delivery and enhanced immunogenicity.
- Published in:
- PLoS ONE, 2017, v. 12, n. 12, p. 1, doi. 10.1371/journal.pone.0190312
- By:
- Publication type:
- Article
Immunogenicity of Self-Associated Aggregates and Chemically Cross-Linked Conjugates of the 42 kDa Plasmodium falciparum Merozoite Surface Protein-1.
- Published in:
- PLoS ONE, 2012, v. 7, n. 6, p. 1, doi. 10.1371/journal.pone.0036996
- By:
- Publication type:
- Article
Pfs230 yields higher malaria transmission-blocking vaccine activity than Pfs25 in humans but not mice.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Safety and Immunogenicity of Pfs25-EPA/Alhydrogel<sup>®</sup>, a Transmission Blocking Vaccine against Plasmodium falciparum: An Open Label Study in Malaria Naïve Adults.
- Published in:
- PLoS ONE, 2016, v. 11, n. 10, p. 1, doi. 10.1371/journal.pone.0163144
- By:
- Publication type:
- Article
mRNA vaccines expressing malaria transmission-blocking antigens Pfs25 and Pfs230D1 induce a functional immune response.
- Published in:
- NPJ Vaccines, 2024, v. 9, n. 1, p. 1, doi. 10.1038/s41541-023-00783-y
- By:
- Publication type:
- Article
A Method for Producing Protein Nanoparticles with Applications in Vaccines.
- Published in:
- PLoS ONE, 2016, v. 11, n. 3, p. 1, doi. 10.1371/journal.pone.0138761
- By:
- Publication type:
- Article